Filed before 2025Filed 9 November 2016
IRX Therapeutics, Inc. raised $6.4M
IRX Therapeutics, Inc., a biotech company based in New York, NY, raised $6.4M in a new debt round, according to a filing dated 9 November 2016.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 9 November 2016
- Round
- Debt round
- Amount sold
- $6.4M
- Offering size
- $8M
- Investors so far
- 4
- Based in
- New York, NY
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 57% of the 1,506 tracked raises with an amount filed in 2016, and than 54% of the 120 in biotech.
IRX Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 29 Aug 2017 | Amended filing | $33.2M | Another raise |
| 12 Jan 2017 | New filing | $13.2M | Another raise |
| 9 Nov 2016 | New filing | $6.4M | This raise |
| 13 May 2016 | New filing | $2M | Another raise |
More with AEM on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.